000 01958 a2200565 4500
005 20250517095842.0
264 0 _c20180718
008 201807s 0 0 eng d
022 _a1477-0962
024 7 _a10.1177/0961203316651738
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFeng, X
245 0 0 _aArtesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
_h[electronic resource]
260 _bLupus
_cJan 2017
300 _a62-72 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAntimalarials
_xadministration & dosage
650 0 4 _aArtemisinins
_xadministration & dosage
650 0 4 _aArtesunate
650 0 4 _aBlotting, Western
650 0 4 _aCase-Control Studies
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aFemale
650 0 4 _aGene Expression Regulation
_xdrug effects
650 0 4 _aHuman Umbilical Vein Endothelial Cells
650 0 4 _aHumans
650 0 4 _aInterferon Type I
_xmetabolism
650 0 4 _aInterferon-alpha
_xadministration & dosage
650 0 4 _aIntramolecular Oxidoreductases
_xdrug effects
650 0 4 _aLeukocytes, Mononuclear
_xdrug effects
650 0 4 _aLupus Erythematosus, Systemic
_xdrug therapy
650 0 4 _aMacrophage Migration-Inhibitory Factors
_xdrug effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPhosphorylation
650 0 4 _aReal-Time Polymerase Chain Reaction
650 0 4 _aSTAT1 Transcription Factor
_xgenetics
650 0 4 _aTime Factors
650 0 4 _aYoung Adult
700 1 _aChen, W
700 1 _aXiao, L
700 1 _aGu, F
700 1 _aHuang, J
700 1 _aTsao, B P
700 1 _aSun, L
773 0 _tLupus
_gvol. 26
_gno. 1
_gp. 62-72
856 4 0 _uhttps://doi.org/10.1177/0961203316651738
_zAvailable from publisher's website
999 _c26063777
_d26063777